Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Return on Assets: 2017-2025

Historic Return on Assets for Organogenesis Holdings (ORGO) over the last 8 years, with Sep 2025 value amounting to -0.02%.

  • Organogenesis Holdings' Return on Assets changed negligibly% to -0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.02%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of -0.02% for FY2024, which is 3.00% down from last year.
  • Latest data reveals that Organogenesis Holdings reported Return on Assets of -0.02% as of Q3 2025, which was up 50.98% from -0.04% recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Return on Assets ranged from a high of 0.23% in Q4 2021 and a low of -0.06% during Q1 2025.
  • Over the past 3 years, Organogenesis Holdings' median Return on Assets value was -0.02% (recorded in 2024), while the average stood at -0.01%.
  • In the last 5 years, Organogenesis Holdings' Return on Assets spiked by 40bps in 2021 and then declined by 20bps in 2022.
  • Over the past 5 years, Organogenesis Holdings' Return on Assets (Quarterly) stood at 0.23% in 2021, then declined by 20bps to 0.03% in 2022, then fell by 2bps to 0.01% in 2023, then decreased by 3bps to -0.02% in 2024, then remained steady at -0.02% in 2025.
  • Its last three reported values are -0.02% in Q3 2025, -0.04% for Q2 2025, and -0.06% during Q1 2025.